We are live on ! Find out more

6 hedge funds and large institutions have $199K invested in iHuman in 2024 Q4 according to their latest regulatory filings, with 1 funds opening new positions, 2 increasing their positions, 1 reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

123% more capital inflows, than outflows

Capital inflows: $62K | Capital outflows: $27.8K

100% more repeat investments, than reductions

Existing positions increased: 2 | Existing positions reduced: 1

0.04% more ownership

Funds ownership: 0.18% → 0.23% (+0.04%)

0% more funds holding

Funds holding: 6 → 6 (0)

0% more first-time investments, than exits

New positions opened: 1 | Existing positions closed: 1

Holders
6
Holders Change
–
Holders Change %
0%
% of All Funds
0.08%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
1
Increased
2
Reduced
1
Closed
1
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Sellers

Rank Fund Capital Flow
1
Two Sigma Securities
Two Sigma Securities
New York
-$25.6K
2
UBS Group
UBS Group
Switzerland
-$2.16K

IH Hedge Fund Activity: Q4 2024 in Review

6 of the 7,621 institutional investors tracked by Wall St. Rank reported a position in iHuman (IH) for Q4 2024, worth a combined $199K — down 9.3% from $219K a quarter earlier.

Fund positioning in IH was balanced in Q4 2024: 1 fund opened new positions, 1 closed out, 2 added to existing stakes and 1 trimmed.

The largest buyer was Morgan Stanley, adding an estimated $39.1K. The largest seller was Two Sigma Securities, exiting entirely with an estimated $25.6K sold.

  • 6 institutional investors held iHuman (IH) as of Q4 2024, unchanged from Q3 2024.
  • Funds reported $199K of iHuman stock for Q4 2024, down 9.3% quarter-over-quarter.
  • 1 fund opened new iHuman positions in Q4 2024 and 1 closed out, a net change of 0 holders.
  • The largest iHuman buyer in Q4 2024 was Morgan Stanley, an estimated $39.1K added.
  • The largest iHuman seller in Q4 2024 was Two Sigma Securities, an estimated $25.6K sold.

Based on aggregated 13F filings for Q4 2024.